project id: TCGA-BLCA; case submitter id: TCGA-HQ-A2OF; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.1; rna integrity number: 9.8; age at index: 52; days to birth: -19016; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; age at diagnosis: 19016; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1947.0; icd 10 code: C67.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Dome of bladder; synchronous malignancy: No; tissue or organ of origin: Dome of bladder; tumor grade: Not Reported; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-HQ-A2OF-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0;